Cross-sectional Survey on Patients With Urinary Tract Infections in Puy-de-Dôme : Epidemiology of Recurrent Urinary Tract Infections and Risk Factors

Urinary Tract Infections Clinical Trial

— IUR63  

Official title:

Cross-sectional Survey on Patients With Urinary Tract Infections in Puy-de-Dôme : Epidemiology of Recurrent Urinary Tract Infections and Risk Factors

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04361864
• Other study ID #: RNI 2019 LESENS
• Secondary ID: 2019-A02703-54
• Status: Completed
• Start date: January 15, 2021
• Est. completion date: February 2, 2021

Study information

• Verified date: May 2021
• Source: University Hospital, Clermont-Ferrand
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Urinary tract infections (UTI) are an important part of infectious diseases. For some patients, those infections are recurrent and have many consequences such as altered quality of life, recurrent symptoms, antibiotics overuse… The primary purpose of this study is to estimate the proportion of patients in Puy-de-Dôme with recurrent urinary tract infections among patients with at least one UTI during 2019. The secondary purposes are : characteristics of patients with recurrent UTI, by sex ; determine predictive factors of recurrent UTI, by sex ; describe bacterial ecology of recurrent UTI and the proportion of multi-resistant bacteria.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 561
• Est. completion date: February 2, 2021
• Est. primary completion date: February 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patient from 18 years old
• affiliated to the french healthcare system
• with at least one urinary tract infection during year 2019
• has accepted email contact with CPAM 63 (Caisse Primaire d'Assurance Maladie du Puy-de-Dôme)

Exclusion Criteria:

• pregnancy during year 2019
• none urinary tract infection reported in 2019

Related Conditions & MeSH terms

• Communicable Diseases
• Infection
• Urinary Tract Infections

Locations

Country	Name	City	State
France	Chu Clermont Ferrand	Clermont-Ferrand

Sponsors (2)

Lead Sponsor	Collaborator
University Hospital, Clermont-Ferrand	Caisse Primaire d'Assurance Maladie du Puy-de-Dôme

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of recurrent urinary tract infections	Proportion, with its 95% confidence interval, of recurrent urinary tract infections, by sex, in the population of Puy-de-Dôme who reported having had at least one urinary tract infection in the year 2019.; The diagnosis of recurrent urinary tract infection will be at least 3 urinary tract infections in one year	During year 2019
Secondary	age in year	Risk factors of recurrent urinary tract infections	day 1
Secondary	sexe	Risk factors of recurrent urinary tract infections	day 1
Secondary	, medical and surgical history	Risk factors of recurrent urinary tract infections	day 1
Secondary	life habits	Risk factors of recurrent urinary tract infections	day 1
Secondary	number of visits at the general practitioner	measure of healthcare consumption with the number of visits at the general practitioner performed	during year 2019
Secondary	number of urinalysis	measure of healthcare consumption with the number of urinalysis performed	during year 2019
Secondary	number of antibiotic therapies	measure of healthcare consumption with the number of antibiotic therapies performed	during year 2019
Secondary	quality of life	quality of life evaluated with a self-reported questionnaire inspired by the Leicester Impact Scale	during year 2019
Secondary	bacteriological characteristics of recurrent urinary tract infections	evaluated with results of urinalysis, bacterial identification and antimicrobial susceptibility	during year 2019